{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:25:10Z","timestamp":1790857510808,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,3,16]],"date-time":"2004-03-16T00:00:00Z","timestamp":1079395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1038\/sj.ijo.0802625","type":"journal-article","created":{"date-parts":[[2004,3,16]],"date-time":"2004-03-16T10:13:33Z","timestamp":1079432013000},"page":"783-789","source":"Crossref","is-referenced-by-count":128,"title":["Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients"],"prefix":"10.1038","volume":"28","author":[{"given":"M","family":"Bajaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Suraamornkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L J","family":"Hardies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Pratipanawatr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"DeFronzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,3,16]]},"reference":[{"key":"BF0802625_CR1","first-page":"177","volume":"5","author":"RA DeFronzo","year":"1997","unstructured":"DeFronzo RA . Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 1997; 5: 177\u2013269.","journal-title":"Diabetes Rev"},{"key":"BF0802625_CR2","first-page":"377","volume":"12","author":"JP Felber","year":"1988","unstructured":"Felber JP, Golay A, Jequier E, Curchod B, Temler E, DeFronzo RA, Ferrannini E . The metabolic consequences of long-term human obesity. Int J Obes Relat Metab Disord 1988; 12: 377\u2013389.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0802625_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1172\/JCI10842","volume":"106","author":"BB Kahn","year":"2000","unstructured":"Kahn BB, Flier JS . Obesity and insulin resistance. J Clin Invest 2000; 106: 473\u2013481.","journal-title":"J Clin Invest"},{"key":"BF0802625_CR4","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1073\/pnas.98.2.502","volume":"98","author":"CM Steppan","year":"2001","unstructured":"Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, Enders GH, Silberg DG, Wen X, Wu GD, Lazar MA . A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 2001; 98: 502\u2013506.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF0802625_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35053000","volume":"409","author":"CM Steppan","year":"2001","unstructured":"Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA . The hormone resistin links obesity to diabetes. Nature 2001; 409: 307\u2013312.","journal-title":"Nature"},{"key":"BF0802625_CR6","doi-asserted-by":"publisher","first-page":"25651","DOI":"10.1074\/jbc.C100189200","volume":"276","author":"JM Way","year":"2001","unstructured":"Way JM, Gorgun CZ, Tong Q, Uysal KT, Brown KK, Harrington WW, Oliver Jr WR, Willson TM, Kliewer SA, Hotamisligil GS . Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 2001; 276: 25651\u201325653.","journal-title":"J Biol Chem"},{"key":"BF0802625_CR7","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.2337\/diabetes.50.10.2199","volume":"50","author":"DB Savage","year":"2001","unstructured":"Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O'Rahilly S . Resistin \/ Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 2001; 50: 2199\u20132202.","journal-title":"Diabetes"},{"key":"BF0802625_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1172\/JCI16521","volume":"111","author":"MW Rajala","year":"2003","unstructured":"Rajala MW, Obici S, Scherer PE, Rossetti L . Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest 2003; 111: 225\u2013230.","journal-title":"J Clin Invest"},{"key":"BF0802625_CR9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0006-291X(02)02841-3","volume":"300","author":"L Patel","year":"2003","unstructured":"Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Macphee CH, Smith SA . Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003; 300: 472\u2013476.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF0802625_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0140-6736(02)07281-1","volume":"359","author":"CL McTernan","year":"2002","unstructured":"McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S . Resistin, central obesity, and type 2 diabetes. Lancet 2002; 359: 46\u201347.","journal-title":"Lancet"},{"key":"BF0802625_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0014-5793(01)02968-4","volume":"507","author":"F Haugen","year":"2001","unstructured":"Haugen F, Jorgensen A, Drevon CA, Trayhurn P . Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes. FEBS Lett 2001; 507: 105\u2013108.","journal-title":"FEBS Lett"},{"key":"BF0802625_CR12","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.1210\/jc.2003-030898","volume":"88","author":"PG McTernan","year":"2003","unstructured":"McTernan PG, Fisher FM, Valsamakis G, Chetty R, Harte A, McTernan CL, Clark PM, Smith SA, Barnett AH, Kumar S . Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab 2003; 88: 6098\u20136106.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF0802625_CR13","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2337\/diabetes.52.7.1611","volume":"52","author":"SR Smith","year":"2003","unstructured":"Smith SR, Bai F, Charbonneau C, Janderova L, Argyropoulos G . A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 2003; 52: 1611\u20131618.","journal-title":"Diabetes"},{"key":"BF0802625_CR14","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.2337\/diabetes.52.6.1364","volume":"52","author":"M Bajaj","year":"2003","unstructured":"Bajaj M, Suraamornkul S, Pratipanawatr T, Hardies LJ, Pratipanawatr W, Glass L, Cersosimo E, Miyazaki Y, DeFronzo RA . Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes. Diabetes 2003; 52: 1364\u20131370.","journal-title":"Diabetes"},{"key":"BF0802625_CR15","first-page":"841","volume":"19","author":"T Goto","year":"1995","unstructured":"Goto T, Onuma T, Takebe K, Kral JG . The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 1995; 19: 841\u2013845.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0802625_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2337\/diabetes.49.5.749","volume":"49","author":"L Ryysy","year":"2000","unstructured":"Ryysy L, Hakkinen A, Goto T, Vehkavaara S, Westerbacka J, Halavaara J, Yki-Jarvinen H . Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorbtion are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 2000; 49: 749\u2013758.","journal-title":"Diabetes"},{"key":"BF0802625_CR17","first-page":"846","volume":"19","author":"MA Banerji","year":"1995","unstructured":"Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE, Kral JG . Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord 1995; 19: 846\u2013850.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0802625_CR18","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/00005176-199703000-00015","volume":"24","author":"T Kawasaki","year":"1997","unstructured":"Kawasaki T, Hashimoto N, Kikuchi T, Takahashi H, Uchiyama M . The relationship between fatty liver and hyperinsulinemia in obese Japanese children. J Pediatr Gastroenterol Nutr 1997; 24: 317\u2013321.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"BF0802625_CR19","first-page":"275","volume":"24","author":"JF Silverman","year":"1989","unstructured":"Silverman JF, Pories WJ, Caro JF . Liver pathology in diabetes mellitus and morbid obesity: clinical, pathological, and biochemical considerations. Pathol Annu 1989; 24: 275\u2013302.","journal-title":"Pathol Annu"},{"key":"BF0802625_CR20","doi-asserted-by":"publisher","first-page":"E906","DOI":"10.1152\/ajpendo.00117.2003","volume":"285","author":"DE Kelley","year":"2003","unstructured":"Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC . Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 2003; 285: E906\u2013E916.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BF0802625_CR21","first-page":"E214","volume":"237","author":"R DeFronzo","year":"1979","unstructured":"DeFronzo R, Tobin J, Andres R . Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214\u2013E223.","journal-title":"Am J Physiol"},{"key":"BF0802625_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.7326\/0003-4819-131-4-199908170-00008","volume":"131","author":"RA DeFronzo","year":"1999","unstructured":"DeFronzo RA . Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999; 131: 281\u2013303.","journal-title":"Ann Intern Med"},{"key":"BF0802625_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1749-6632.1987.tb32915.x","volume":"508","author":"PA Bottomley","year":"1987","unstructured":"Bottomley PA . Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 1987; 508: 333\u2013348.","journal-title":"Ann NY Acad Sci"},{"key":"BF0802625_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1172\/JCI114142","volume":"84","author":"LC Groop","year":"1989","unstructured":"Groop LC, Bonadonna RC, Del Prato S, Ratheiser K, Zyck K, DeFronzo RA . Glucose and free fatty acid metabolism in non-insulin-dependant diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 1989; 84: 205\u2013213.","journal-title":"J Clin Invest"},{"key":"BF0802625_CR25","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1749-6632.1959.tb44923.x","volume":"82","author":"R Steele","year":"1959","unstructured":"Steele R . Influence of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 1959; 82: 420\u2013430.","journal-title":"Ann N Y Acad Sci"},{"key":"BF0802625_CR26","doi-asserted-by":"publisher","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","volume":"270","author":"JM Lehmann","year":"1995","unstructured":"Lehmann JM, Moore LB, Smith-Oliver TA, Wilkinson WO, Willson TM, Kliewer SA . An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995; 270: 12953\u201312956.","journal-title":"J Biol Chem"},{"key":"BF0802625_CR27","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.2337\/diabetes.46.9.1393","volume":"46","author":"S Hallakou","year":"1997","unstructured":"Hallakou S, Doare F, Foufelle F, Kergoat M, Guerre-Millo M, Berthault MF, Dugail I, Morin J, Auwerx J, Ferre P . Pioglitazone induces in vivo adipocyte differentiation in obese Zucker fa\/fa rat. Diabetes 1997; 46: 1393\u20131399.","journal-title":"Diabetes"},{"key":"BF0802625_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1432-1033.1996.0001u.x","volume":"239","author":"KG Lambe","year":"1996","unstructured":"Lambe KG, Tugwood JD . A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs. Eur J Biochem 1996; 239: 1\u20137.","journal-title":"Eur J Biochem"},{"key":"BF0802625_CR29","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1210\/jcem.87.6.8567","volume":"87","author":"Y Miyazaki","year":"2002","unstructured":"Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K, Mandarino LJ, DeFronzo RA . Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 2002; 87: 2784\u20132791.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"BF0802625_CR30","first-page":"69A","volume":"51","author":"Y Miyazaki","year":"2002","unstructured":"Miyazaki Y, Hardies LJ, Wajcberg E, Glass L, Triplett C, Bajaj M, Cersosimo E, Mandarino LJ, DeFronzo RA . Effect of pioglitazone on liver fat content, abdominal fat distribution and insulin sensitivity in patients with type 2 diabetes mellitus. Diabetes 2002; 51 (Suppl 2): 69A.","journal-title":"Diabetes"},{"key":"BF0802625_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2337\/diabetes.51.3.797","volume":"51","author":"AB Mayerson","year":"2002","unstructured":"Mayerson AB, Hundal RS, Dufour S, Lebon V, Befroy D, Cline GW, Enocksson S, Inzucchi SE, Shulman GI, Petersen KF . The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes 2002; 51: 797\u2013802.","journal-title":"Diabetes"},{"key":"BF0802625_CR32","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.2337\/diabetes.51.6.1737","volume":"51","author":"N Shojima","year":"2002","unstructured":"Shojima N, Sakoda H, Ogihara T, Fujishiro M, Katagiri H, Anai M, Onishi Y, Ono H, Inukai K, Abe M, Fukushima Y, Kikuchi M, Oka Y, Asano T . Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells. Diabetes 2002; 51: 1737\u20131744.","journal-title":"Diabetes"},{"key":"BF0802625_CR33","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1006\/bbrc.2001.5460","volume":"286","author":"GB Moore","year":"2001","unstructured":"Moore GB, Chapman H, Holder JC, Lister CA, Piercy V, Smith SA, Clapham JC . Differential regulation of adipocytokine mRNAs by rosiglitazone in db\/db mice. Biochem Biophys Res Commun 2001; 286: 735\u2013741.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF0802625_CR34","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.bbrc.2003.09.093","volume":"310","author":"RZ Yang","year":"2003","unstructured":"Yang RZ, Huang Q, Xu A, McLenithan JC, Eison JA, Shuldiner AR, Alkan S, Gong DW . Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem Biophys Res Commun 2003; 310: 927\u2013935.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF0802625_CR35","doi-asserted-by":"publisher","first-page":"11252","DOI":"10.1074\/jbc.C100028200","volume":"276","author":"KH Kim","year":"2001","unstructured":"Kim KH, Lee K, Moon YS, Sul HS . A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001; 276: 11252\u201311256.","journal-title":"J Biol Chem"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/0802625.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0802625","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0802625.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T07:30:14Z","timestamp":1684222214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/0802625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,16]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["BF0802625"],"URL":"https:\/\/doi.org\/10.1038\/sj.ijo.0802625","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,16]]}}}